on Biophytis (EPA:ALBPS)
Biophytis Participates in First Longevity Summit
Biophytis SA, a pioneer in transformative longevity therapies, announced its participation in the inaugural Longevity Summit 2026. The event took place at the French National Academy of Medicine in Paris, supported by French President Emmanuel Macron. The summit is a pivotal gathering in France, dedicated to addressing challenges in healthy aging. It brought together 150 leaders from various sectors to discuss geroscience advancements, AI healthcare applications, and aging prevention strategies.
Biophytis' involvement underscores its commitment to contributing to aging management discourse. The company showcased its therapeutic approach focused on mobility and autonomy. CEO Stanislas Veillet engaged in panel discussions with experts on aging-related challenges. This aligns with Biophytis' strategy of leading in age-related disease solutions.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Biophytis news